Market Introduction
Hematology Analyzers and reagents are healthcare products and consumables intended to identify and count the individual blood cells in a high-speed manner and highly effective. They are used in the diagnosis and treatment of a wide range of diseases related to red blood cells, white blood cells, platelets, blood vessels, bone marrow, lymph nodes, spleen, and the proteins involved in bleeding and clotting. These instruments have substituted the conventional methods of measuring blood cells individually under a microscope, carried out previously by the lab technicians. These devices provide more precise and useful blood cell results and other related information from the blood sample.
Market Overview and Dynamics
The Asia Pacific hematology analyzers and reagents market is expected to reach US$ 2,709.54million in 2027 from US$ 1,456.83million in 2019. The market is estimated to grow with a CAGR of 8.1% from 2020-2027. The growth of this market is estimated to grow owing to key driving factors such as the rising cases of blood disorders and cancers across the Asia Pacific and the higher adoption of point-of-care testing methods. However, the market growth is likely to be hindered owing to the risks associated with damaged hematology analyzers and reagents resulting in product recalls.
Key Market Segments
Based on product and service, the hematology analyzers and reagents market is segmented into hematology products and services, hemostasis products and services, and immunohematology products and services. The hematology products and services segment is further subdivided into instruments, reagents and consumables, and services. The hemostasis products and services segment is further subdivided into instruments, reagents and consumables, and services. The immunohematology products and services segment is further subdivided into instruments, reagents and consumables, and services. Based on application, the hematology analyzers and reagents market is segmented into anemia, blood cancer, hemorrhagic conditions, infection related conditions, immune system related conditions, and others. Based on end-user, the hematology analyzers and reagents market, is segmented into hospital laboratories, commercial service providers, government reference laboratories, and research and academic institutes.
Major Sources and Companies Listed
Some of the major primary and secondary sources for hematology analyzers and reagents market included in the report are the Indian Council of Medical Research (ICMR), Hemophilia Federation India (HFI), and others.
Reasons to buy the report
ASIA PACIFIC HEMATOLOGY ANALYZERS AND REAGENTS MARKET SEGMENTATION
By Product and Service
By Country
Company Profiles
| Report Attribute | Details |
|---|---|
| Market size in 2019 | US$ 1,456.83 Million |
| Market Size by 2027 | US$ 2,709.54 Million |
| CAGR (2020 - 2027) | 8.1% |
| Historical Data | 2017-2018 |
| Forecast period | 2020-2027 |
| Segments Covered |
By Product and Service
|
| Regions and Countries Covered |
Asia-Pacific
|
| Market leaders and key company profiles |
|
The Asia Pacific Hematology Analyzers and Reagents Market is valued at US$ 1,456.83 Million in 2019, it is projected to reach US$ 2,709.54 Million by 2027.
As per our report Asia Pacific Hematology Analyzers and Reagents Market, the market size is valued at US$ 1,456.83 Million in 2019, projecting it to reach US$ 2,709.54 Million by 2027. This translates to a CAGR of approximately 8.1% during the forecast period.
The Asia Pacific Hematology Analyzers and Reagents Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Asia Pacific Hematology Analyzers and Reagents Market report:
The Asia Pacific Hematology Analyzers and Reagents Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Asia Pacific Hematology Analyzers and Reagents Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Asia Pacific Hematology Analyzers and Reagents Market value chain can benefit from the information contained in a comprehensive market report.
Please tell us your area of interest
(Market Segments/ Regions and Countries/ Companies)